⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6625546 | 0.97 | — | — | |
| SCHEMBL6854231 | 0.90 | — | — | |
| SCHEMBL23759217 | 0.71 | — | — | |
| SCHEMBL20439268 | 0.71 | — | — | |
| SCHEMBL34472535 | 0.71 | — | — | |
| SCHEMBL27658084 | 0.69 | — | — | |
| SCHEMBL15519660 | 0.69 | — | — | |
| SCHEMBL28760226 | 0.69 | — | — | |
| SCHEMBL7111408 | 0.65 | — | — | |
| SCHEMBL7112652 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10752606-B2 | Methods for treating protozoan infections | NEOCULI PTY LTD. (AU) | 2020-08-25 | — | — | US | claimed |
| US-20200102287-A1 | METHODS FOR TREATING PROTOZOAN INFECTIONS | NEOCULI PTY LTD (AU) | 2020-04-02 | — | — | US | claimed |
| US-10562880-B2 | Methods for treating protozoan infections | NEOCULI PTY LTD. (AU) | 2020-02-18 | — | — | US | claimed |
| US-20190330178-A1 | METHODS FOR TREATING PROTOZOAN INFECTIONS | NEOCULI PTY LTD (AU) | 2019-10-31 | — | — | US | claimed |
| US-10392363-B2 | Methods for treating protozoan infections | NEOCULI PTY LTD. (AU) | 2019-08-27 | — | — | US | claimed |
| CN-109761909-A | N- (4- (pyrimidine -4- amino) phenyl) sulfonamide inhibitors or its pharmaceutical salt, preparation method and the usage | 中国药科大学 | 2019-05-17 | — | — | CN | claimed |
| US-20170291886-A1 | METHODS FOR TREATING PROTOZOAN INFECTIONS | NEOCULI PTY LTD (AU) | 2017-10-12 | — | — | US | claimed |
| CN-103709087-B | The preparation method of a kind of alpha-pyrrolidone | 焦作中维特品药业有限公司 | 2016-06-08 | — | — | CN | claimed |
| CN-1310892-C | Dithiocarbamate derivatives and their use as antibacterial agents | MEDAC KLINISCHE SPEZIALPRAEP (IT) | 2007-04-18 | — | — | CN | claimed |
| CN-1615301-A | Dithiocarbamate derivatives and their use as antibacterial agents | MEDAC KLINISCHE SPEZIALPRAEP (IT) | 2005-05-11 | — | — | CN | claimed |
| CN-1142832-A | CS-1 mimetics, compositions and methods utilizing the same | CYTEL CORP (US) | 1997-02-12 | — | — | CN | claimed |
| US-20250312349-A1 | COMPOSITION AND METHODS OF TREATING INTRACELLULAR PATHOGEN INFECTION | UNIV HOSPITALS CLEVELAND MEDICAL CENTER (US) | 2025-10-09 | — | — | US | disclosed |
| EP-4402138-B1 | 3-PHENOXYAZETIDIN-1-YL-HETEROARYL PYRROLIDINE DERIVATIVES AND THE USE THEREOF AS MEDICAMENT | BOEHRINGER INGELHEIM INT (DE) | 2025-08-27 | — | — | EP | disclosed |
| US-20250146050-A1 | STABILISATION OF BIOLOGICAL SAMPLES | QIAGEN GMBH (DE) | 2025-05-08 | — | — | US | disclosed |
| US-20250122555-A1 | STABILISATION OF BIOLOGICAL SAMPLES | QIAGEN GMBH (DE) | 2025-04-17 | — | — | US | disclosed |
| US-5932674-A | MOLDING MATERIALS; CONTACT LENSES | NOVARTIS AG (CH) | 1999-08-03 | — | — | US | disclosed |
| EP-0807265-A1 | CROSSLINKED POLYMERS | Novartis AG (CH) | 1997-11-19 | — | — | EP | disclosed |
| CN-1137541-A | Synergistic stabilizer mixture | CIBA GEIGY AG (CH) | 1996-12-11 | — | — | CN | disclosed |
| CN-1136048-A | Synergistic stabilizer mixture | CIBA GEIGY AG (CH) | 1996-11-20 | — | — | CN | disclosed |
| WO-1996024074-A1 | CROSSLINKED POLYMERS | NOVARTIS AG (CH) | 1996-08-08 | — | — | WO | disclosed |